The Department of Investigational Cancer Therapeutics has developed a world-class clinical trials program. Our objective is to perform molecular profiling and match patients with novel, targeted drugs in the early clinical trials setting.


Observer Program 

We offer one short-term observer position each month.  

Appointments & Referrals

For a referral to clinical trials with a new targeted drug, call (713) 792-1160, or visit our Contact Information page.